Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Enrich Therapeutics Logo
Enrich Therapeutics Growth Score
37
CB Rank
135231
Heat Score
71
Enrich Therapeutics is a biotechnology startup.
Founded
obfuscation
PrivateGrant Worcester, Massachusetts, United States1-10 www.enrichtx.com/
Biotechnology
Health Care
Overview

Enrich Therapeutics
Total Funding
obfuscation
Growth Score
37
Heat Score
71

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score37
-3 pts
in past quarter
Heat Score 71
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Enrich Therapeutics

CB Rank
135231
Enrich Therapeutics is a biotechnology startup.
Founded
obfuscation
PrivateGrant Worcester, Massachusetts, United States1-10 www.enrichtx.com/
Biotechnology
Health Care

Funding Rounds

Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Enrich Therapeutics Inc.
Operating Status Active
Company Type For Profit
Founders  Qi Zhao
About the Company
Enrich Therapeutics is a biotechnology startup focused on the development of novel single-cell isolation platform along with the critical life science applications.
Phone Number 203-815-0259
Contact Email inquiry@enrichtx.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Research & Development

Enrich Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Enrich Therapeutics Logo
Grant - Enrich Therapeutics
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Enrich Therapeutics Logo
Grant - Enrich Therapeutics
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Enrich Therapeutics Logo
Grant - Enrich Therapeutics
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Enrich Therapeutics Logo
Grant - Enrich Therapeutics
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Enrich Therapeutics Logo
Grant - Enrich Therapeutics
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Enrich Therapeutics Logo
Grant - Enrich Therapeutics
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Enrich Therapeutics Logo
Grant - Enrich Therapeutics
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Enrich Therapeutics Logo
Grant - Enrich Therapeutics
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Enrich Therapeutics Logo
Grant - Enrich Therapeutics
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant
obfuscation
Grant - Enrich Therapeutics Logo
Grant - Enrich Therapeutics
1
obfuscation
National Institute of Allergy and Infectious DiseasesGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 3

Employee Profiles

News

News and Press

News•Apr 29, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

3Enrich Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Mobile Non Scaleable Content.

Total IP

2The intellectual property of Enrich Therapeutics includes 2 registered patents primarily in the 'Testing' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Enrich Therapeutics's headquarters? Enrich Therapeutics is located in Worcester, Massachusetts, United States.Who invested in Enrich Therapeutics? Enrich Therapeutics has 4 investors including National Institute of Allergy and Infectious Diseases and  Boston Harbor Angels.When was the last funding round for Enrich Therapeutics? Enrich Therapeutics closed its last funding round on
obfuscation
from a Grant round.How much funding has Enrich Therapeutics raised to date? Enrich Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(48b9b99 1)
|